Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Frontiers in Genetics|August 6, 2025
Filaggrin<sup>High</sup> melanomas exhibit active FGFR and allergic signatures with impaired GNA14 and Th1 signaturesGoodwin G Jinesh, Isha GodwinBiological Reviews of the Cambridge Philosophical Society|October 31, 2019
The genetic script of metastasisGoodwin G Jinesh, Andrew S BrohlCell Death Discovery|June 6, 2017
RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency programGoodwin G Jinesh, Ashish M KamatCell Death Discovery|May 27, 2016
Endocytosis and serpentine filopodia drive blebbishield-mediated resurrection of apoptotic cancer stem cellsGoodwin G Jinesh, Ashish M KamatBiofactors (Oxford, England)|September 28, 2016
Blebbishields and mitotic cells exhibit robust macropinocytosisGoodwin G Jinesh, Ashish M KamatSignal Transduction and Targeted Therapy|August 23, 2022
Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasisGoodwin G Jinesh, Andrew S BrohlCancer Research|September 1, 2017
The Blebbishield Emergency Program Overrides Chromosomal Instability and Phagocytosis Checkpoints in Cancer Stem CellsGoodwin G Jinesh, Ashish M KamatPlos One|October 19, 2018
Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancersGoodwin G Jinesh, Elsa R Flores, Andrew S BrohlThe Biochemical Journal|October 29, 2015
Smac mimetic with TNF-α targets Pim-1 isoforms and reactive oxygen species production to abrogate transformation from blebbishieldsGoodwin G Jinesh, Naomi M Laing, Ashish M KamatApoptosis : an International Journal on Programmed Cell Death|September 22, 2016
Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacksGoodwin G Jinesh, Sharada Mokkapati, Keyi Zhu, et al.Pageof 3